Cranial aspergillosis in a patient receiving ibrutinib for chronic lymphocytic leukemia

被引：10
作者：
Beresford, Rohan [1 ]
Dolot, Virginia [1 ]
Foo, Hong [1 ,2 ]
机构：
[1] NSW Hlth Pathol South West Sydney, Dept Microbiol & Infect Dis, Sydney, NSW, Australia
[2] Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia
来源：
MEDICAL MYCOLOGY CASE REPORTS | 2019年 / 24卷
关键词：
Aspergillosis; Ibrutinib; Cerebral abscess; Chronic lymphocytic leukemia;
D O I：
10.1016/j.mmcr.2019.02.005
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Cerebral abscess due to Aspergillus species is a relatively uncommon presentation, even amongst immunocompromised patients. However it is increasingly being recognized as a complication of ibrutinib therapy in patients with chronic lymphocytic leukemia. We present a case of cerebral abscesses caused by Aspergillus felis in a patient receiving ibrutinib for chronic lymphocytic leukemia.
引用
收藏
页码：27 / 29
页数：3
相关论文
共 50 条
  • [41] The emerging role of ibrutinib in the treatment of chronic lymphocytic leukemia
    Molica, Stefano
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (05) : 543 - 546
  • [42] ALPINE: zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma
    Hillmen, Peter
    Brown, Jennifer R.
    Eichhorst, Barbara F.
    Lamanna, Nicole
    O'Brien, Susan M.
    Qiu, Lugui
    Salmi, Tommi
    Hilger, James
    Wu, Kenneth
    Cohen, Aileen
    Huang, Jane
    Tam, Constantine S.
    FUTURE ONCOLOGY, 2020, 16 (10) : 517 - 523
  • [43] Successful treatment with ribavirine for chronic hepatitis E in chronic lymphocytic leukemia treated with Ibrutinib
    Boudin, Laurys
    Patient, Matthieu
    Tsogou, Precilla Tsitsi Nding
    Romeo, Emilie
    Blade, Jean-Sebastien
    de Jaureguiberry, Jean-Pierre
    BULLETIN DU CANCER, 2019, 106 (01) : 84 - 85
  • [44] Prognostic models in chronic lymphocytic leukemia patients receiving ibrutinib therapy: Results of a comparative performance analysis
    Molica, Stefano
    Baumann, Tycho
    Giannarelli, Diana
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (03) : 425 - 427
  • [45] Hepatitis B Virus Reactivation with Ibrutinib Treatment in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review
    Yildirim, Arzu Altuncekic
    Kurt, Celali
    Ulkuden, Burcu
    Cetinkol, Yeliz
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2024, 30 (01): : 19 - 22
  • [46] Experience with ibrutinib for first-line use in patients with chronic lymphocytic leukemia
    Itchaki, Gilad
    Brown, Jennifer R.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (01) : 3 - 19
  • [47] Ibrutinib for Chronic Lymphocytic Leukemia (CLL): A Single Center Experience in Bogota, Colombia
    Bohorquez, Leonardo
    Abello, Virginia
    Helena Solano, Maria
    Casas, Claudia
    Espinosa, Daniel
    Leon, Guillermo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S285 - S285
  • [48] Effects of ibrutinib on T-cell immunity in patients with chronic lymphocytic leukemia
    Liu, Yanyan
    Song, Yongping
    Yin, Qingsong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and chronic lymphocytic leukemia
    Tucker, David L.
    Rule, Simon A.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 979 - 990
  • [50] Ibrutinib and panitumumab used in combination safely in a patient with metachronous colorectal cancer and chronic lymphocytic leukemia
    Korkmaz, Mustafa
    Eryilmaz, Melek Karakurt
    Karaagac, Mustafa
    Araz, Murat
    Ceneli, Ozcan
    Artac, Mehmet
    ANTI-CANCER DRUGS, 2022, 33 (08) : 765 - 767
12345